Tech Company Financing Transactions
BioQ Pharma Funding Round
BioQ Pharma closed a $55 million financing round on 8/17/2017. Investors included Madryn Asset Management and private investors.
Transaction Overview
Company Name
Announced On
8/17/2017
Transaction Type
Venture Equity
Amount
$55,000,000
Round
Undisclosed
Investors
Madryn Asset Management (Lead Investor) (Avi Amin)
Proceeds Purpose
The proceeds of the investment will be used by BioQ to support product commercialization, scale-up manufacturing and operations, and continue new product development.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1325 Howard St.
San Francisco, CA 94103
USA
San Francisco, CA 94103
USA
Phone
Website
Email Address
Overview
BioQ Pharma is a late stage specialty pharmaceutical company focused on developing and commercializing a portfolio of large volume ready-to-use infusible pharmaceuticals.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Josh Kriesel
Chief Financial Officer
Ronald Pauli
Controller
Christopher Vega
Vice President
Richard Watts
VP - Engineering
Ralph McNall
VP - Marketing
Serena Joshi
VP - Operations
Walter Cleymans
VP - Regulatory Affairs
Greg Meyer
Browse more venture capital transactions:
Prev: 8/17/2017: Reverb Holdings venture capital transaction
Next: 8/17/2017: BayoTech venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs